Cerenis Therapeutics, a pharma startup researching new cardiovascular therapies based on HDL, the so-called good cholesterol, said it has raised a further €10 million in a second close of its Series C financing. This takes […]
Kalamazoo-based NephRx Corp. announced Thursday that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating inflammation of the […]
Issue Media Group, publishers of Model D, Metromode, and Concentrate, in partnership with the New Economy Initiative, announced the launch of Startup, a new Web site devoted exclusively to entrepreneurship in Southeast Michigan.